US 10215762
Method to optimize the treatment of patients with biological drugs
granted A61KA61K39/3955A61K49/00
Quick answer
US patent 10215762 (Method to optimize the treatment of patients with biological drugs) held by PROGENIKA BIOPHARMA, S.A. expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PROGENIKA BIOPHARMA, S.A.
- Grant date
- Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K39/3955, A61K49/00